Investors
Financials
Financial Calendar
January 15, 2026 – Fourth Quarter 2025 Sales
April 15, 2026 – Q1 2026 Sales
April 22, 2026 – 2025 Annual Results
June 4, 2026 – 2026 Annual General Meeting
July 21, 2026 – Q2 2026 Sales
October 8, 2026 – 2026 Half-Year Results
October 20, 2026 – Q3 2026 Sales
Financial Calendar
January 15, 2026 – Fourth Quarter 2025 Sales
April 9, 2026 – 2025 Annual Results
April 16, 2026 – Q1 2026 Sales
June 4, 2026 – 2026 Annual General Meeting
July 21, 2026 – Q2 2026 Sales
October 8, 2026 – 2026 Half-Year Results
October 20, 2026 – Q3 2026 Sales
Q3 2025 Sales
2025 Half-Year Financial Report (free translation)
H1 2025 Sales
Mauna Kea Technologies Extends Its Financial Horizon Beyond the Observation Period of the Safeguard Procedure
Mauna Kea Technologies Reaches Key Milestone in its Safeguard Procedure
Publication of the 2024 Annual Financial Report
2024 Annual Financial Report
FY 2024 Results
Mauna Kea Technologies announces the opening of a safeguard proceeding to restructure its financial liabilities
Full Year 2024 Sales
Mauna Kea Technologies Announces its 2025 Financial Calendar
H1 2024 Financial Results and Q3 2024 Sales
No results found.
News
Mauna Kea Technologies Announces Two New Peer-Reviewed Clinical Studies Confirming the Clinical Value of Cellvizio® and Its Combination with AI for the Diagnosis of Pancreatic Cysts
Mauna Kea Technologies Reports Strong H1 2026 Core Sales Growth
Mauna Kea Technologies to Host a Webinar on July 21, 2026 To Discuss Its First-Half Business Activity
No results found.